Breakthrough Therapy designation granted for LX2006 based on interim data from Phase I/II trials demonstrating clinically meaningful improvements in cardiac and…
CNSide® can quantify leptomeningeal metastases (LM) over time and monitor changes in the expression of multiple targetable mutations CNSide® may…
HONG KONG, Aug. 14, 2025 /PRNewswire/ -- Testing technologies play a pivotal role in disease diagnosis. Currently, flow cytometers are widely…
AI-powered delivery date prediction model shows high accuracy and improved performance over time, with promise for global maternal health impact…
LISLE, Ill., Aug. 13, 2025 /PRNewswire/ -- Forum Health, a leading nationwide provider of functional and integrative medicine, today announced the…
Emerging companies from six countries begin the 18-week startup program in Kansas' capital city TOPEKA, Kan., Aug. 13, 2025 /PRNewswire/ -- In…
Black Book's 18-country survey reveals 74% of health systems advancing large-scale rollouts by 2027, fueled by interoperability, AI readiness, and…
Black Book's 18-country survey reveals 74% of health systems advancing large-scale rollouts by 2027, fueled by interoperability, AI readiness, and…
Rene Veloso, JD, MBA, joins KIFFIK to lead investor relations and secure new funding to fuel clinical operationsRubix Life Sciences…
Rene Veloso, JD, MBA, joins KIFFIK to lead investor relations and secure new funding to fuel clinical operationsRubix Life Sciences…